Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GY.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HW.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FE.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.6.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDBENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.18.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used